SECOR Capital Advisors, LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 185 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$468,000
-71.7%
7,813
-78.3%
0.04%
-70.6%
Q1 2018$1,653,000
+136.1%
36,081
+105.3%
0.14%
+385.7%
Q4 2017$700,000
+56.6%
17,577
-47.1%
0.03%
-77.8%
Q4 2015$447,000
-35.8%
33,249
-18.8%
0.13%
-49.4%
Q2 2015$696,00040,9670.25%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders